オプションチェーンは、Arcus Biosciencesの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Arcus Biosciencesの市場センチメントを評価します。.

Arcus Biosciences (NYSE:RCUS) 株価情報, オプションチェーン

ARCUS BIOSCIENCES INC

Arcus Biosciences

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Analyst Ratings

RCUS

アルカス・バイオサイエンス（Arcus Biosciences）（NYSE:RCUS）の株価予測がまたしても分析され、多くのアナリストの間でさまざまな意見が出された。

アルカス・バイオサイエンス　株価予測を公表

Arcus Biosciences Inc

Oppenheimer analyst Jay Olson assumes Praxis Precision Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRAX#NASDAQ">PRAX</a>) with a Outperform rating and announces Price Target of $97.

News

Price Target

Initiation

PRAX

Oppenheimer Assumes Praxis Precision Medicine at Outperform, Announces Price Target of $97

Shares of DraftKings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) are trading lower Monday after Illinois passed a new budget proposal that includes <a href="https://www.benzinga.com/content/45600567/draftkings-march-madness-miss-wall-street-sees-50-upside">increased taxes on sports betting</a>.
What To Know: The $55.2 billion spending portion of the budget, approved late Saturday night, is expected to raise over $1 billion in new revenue through various tax hikes, including a notable increase targeting online sportsbook operators, according to local news outlet <a href="https://www.chicagotribune.com/2025/06/01/democrats-propose-tax-hikes-on-cigarettes-vaping-and-gambling-to-balance-55b-budget/">Chicago Tribune</a>.
Under the new budget plans, licensed sports betting operators in Illinois will now face a 25-cent tax per wager on their first 20,000 bets each year, as well as a 50-cent tax on each bet after that. This move is expected to impact margins for companies like DraftKings, which generate a substantial portion of their revenue from active betting states like Illinois.
The broader gambling sector reacted negatively to the legislation, which was pushed through by the state's Democratic majority with little time for public review. The new taxes form part of a strategy to close revenue gaps without increasing sales or income taxes, according to state leaders.
The market response reflects concerns that similar tax hikes could be proposed in other states looking to address fiscal shortfalls without directly raising income or sales taxes. For sports betting companies, higher operational taxes in key markets may weigh on profitability and potentially dampen expansion efforts.
Despite the budget's inclusion of several new tax streams, also targeting tobacco, vaping and out-of-state businesses, it&#8217;s the targeted sports betting fees that directly pressured DraftKings' stock price. Investors are now watching to see whether these fiscal strategies in Illinois set a precedent for broader regulatory pressure in the industry.
DKNG Price Action: DraftKings shares were down 7.26% at $33.28 at the time of publication Monday, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="http://ns-as-may-data-shows-sharper-contraction-stubborn-inflation">Trump&#8217;s Manufacturing Narrative Weakens As May Data Shows Sharper Contraction, Stubborn Inflation </a></li>
</ul>
Image via Shutterstock.

Sports Betting

Movers

General

DKNG

DraftKings Stock Is Facing Selling Pressure Monday: What's Going On?

Trevi Therapeutics, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVI#NASDAQ">TRVI</a>) revealed topline results on Monday from its Phase&nbsp;2b&nbsp;CORAL trial of Haduvio for chronic cough in patients with idiopathic pulmonary fibrosis (IPF) (N=165).
The primary endpoint in the CORAL trial was achieved, demonstrating statistically significant reductions in 24-hour cough frequency across all dose groups at week six.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44224649/trevi-therapeutics-reveals-positive-data-from-mid-stage-study-for-chronic-cough-candidate-stock-jumps" rel="noreferrer noopener">Trevi Therapeutics Reveals Positive Data From Mid-Stage Study For Chronic Cough Candidate, Stock Jumps</a>
The 108 mg BID, 54 mg BID and 27 mg BID dose groups achieved reductions from Baseline of 60.2%, 53.4%, and 47.9%, respectively, compared to a placebo reduction from a <a href="https://www.benzinga.com/pressreleases/25/06/n45717780/trevi-therapeutics-announces-positive-topline-results-from-the-phase-2b-coral-trial-of-haduvio-in-" target="_blank" rel="noreferrer noopener">baseline of 16.9%</a>. 
At week six, statistically significant improvements were observed across secondary endpoints in the 108 mg BID and 54 mg BID dose groups.
<h1 class="wp-block-heading">Additional Trial Results</h1>
<ul class="wp-block-list">
<li>A rapid reduction was seen in 24-hour cough frequency at week two with Haduvio, the first time point measured.</li>
<li>A 50% reduction in 24-hour cough frequency at week six versus baseline was seen in 65% of patients on 108 mg BID Haduvio, 63% of patients on 54 mg BID Haduvio and 60% of patients on 27 mg BID Haduvio dose groups, compared to 19% of placebo patients.</li>
<li>A statistically significant response was observed on the cough-severity numerical rating scale (CS-NRS), a secondary endpoint, at week six on Haduvio in both the 108 mg BID and 54 mg BID dose groups.</li>
<li>At week six, the mean reduction on a 0 – 10 scale was 3.0 points for the 108 mg BID, 3.2 points for the 54 mg BID and 2.0 points for the 27 mg BID dose groups, compared to a 1.5-point reduction on placebo.</li>
<li>The 108 mg BID and 54 mg BID dose groups were statistically significant on the patient-reported outcome E-RS: IPF Cough Subscale, a secondary endpoint, with mean relative change from baseline of -42.4% and -43.1%, respectively at week six, compared to -23% for those on placebo at week six.</li>
<li>The 27 mg BID dose group was not statistically significant with a mean relative change from baseline of –31.6%.</li>
</ul>
Discontinuation rates due to adverse events were similar in the combined Haduvio (5.6%) and placebo groups (5%).
TRVI Price Action: Trevi stock is down 10.45% at $5.83 at publication on Monday
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/m-a/25/06/45723960/guardian-pharmacy-strengthens-us-footprint-with-new-seattle-area-acquisition" target="_blank" rel="noreferrer noopener">Guardian Pharmacy Strengthens US Footprint With New Seattle-Area Acquisition</a></li>
</ul>
Photo: Shutterstock

Health Care

Trading Ideas

TRVI

Trevi Therapeutics Showcases Drug That Cuts Cough Frequency In Lung Disease Patients

New ETF filings from VistaShares reveal plans to launch funds that track the top trades of Bill Ackman and Michael Burry, expanding on the <a href="https://www.benzinga.com/etfs/new-etfs/25/03/44196788/exclusive-vistashares-launches-warren-buffett-inspired-etf-filling-a-gap-in-the-market-says-ceo">firm&#8217;s existing ETFs</a> tied to Warren Buffett&#8216;s investments.
What Happened: VistaShares may not be a household name for ETFs yet, but that could soon change with ETFs that will allow investors ways to invest alongside three legendary figures.
New <a href="https://www.sec.gov/Archives/edgar/data/1722388/000199937125006776/vistashares-485apos_052825.htm">filings </a>from the ETF company call for the following future ETFs to be launched:
<ul class="wp-block-list">
<li>VistaShares Pershing Square Select ETF</li>
<li>VistaShares Target 15 Pershing Square Select Income ETF</li>
<li>VistaShares Scion Asset Management Select ETF</li>
<li>VistaShares Target 15 Scion Asset Management Select Income ETF</li>
<li>VistaShares Duquesne Select ETF</li>
<li>VistaShares Target 15 Duquesne Select Income ETF</li>
<li>VistaShares Berkshire Select ETF</li>
</ul>
The ETFs will copy the investments and portfolios of Bill Ackman (Pershing Square), Michael Burry (Scion), and Stanley Druckenmiller (Duquesne). The new Berkshire Select ETF will add to the company's portfolio, which already includes the VistaShares Target 15 Berkshire Select Income (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMAH#NYSE">OMAH</a>).
The new ETFs are actively managed and will trade on the New York Stock Exchange. The main select ETFs will seek to replicate the performance of the underlying index. The target 15 funds will provide more of an income component with investments in options and other items to attempt to maintain an annual income target of 15%. &nbsp;&nbsp;
According to the filing, the VistaShares Pershing Square Select ETF would hold up to 20 stocks that best represent Ackman&#8217;s fund&#8217;s publicly disclosed holdings.
Read Also:<a href="https://www.benzinga.com/etfs/specialty-etfs/25/05/45197995/exclusive-invest-like-buffett-this-etf-ceo-is-riding-the-berkshire-hathaway-buzz"> EXCLUSIVE: &#8216;Invest Like Buffett,&#8217; This ETF CEO Is Riding The Berkshire Hathaway Buzz</a>
Why It's Important: The existing Berkshire fund from VistaShares has attracted over $200 million in assets and is popular with investors, likely leading to the launch of the new ETFs.
One item investors will have to decide before investing in the ETFs is that 13Fs from the likes of Ackman, Burry, Druckenmiller, and Buffett only have to be filed once a quarter, and the holdings may be different than what's reported. The stocks owned may have already increased in value between the time the investment management bought the stock and the time the transaction was disclosed.
Retail investors enjoy copying well-known investors with proven track records, and new products based on these names could offer excitement in the ETF space.
Ackman's most recent 13F filing <a href="https://www.benzinga.com/news/management/25/05/45456642/bill-ackman-loads-up-on-uber-dumps-nike-in-major-q1-portfolio-rebalance">showed several big changes</a>, including swapping out Nike Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) stock for options and taking a position in Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) of more than 30 million shares. Ackman increased positions in Hertz Global Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) and Alphabet Inc Class A (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) shares during the first quarter.
At the end of the first quarter, these were the top holdings in the Pershing Square fund:
<ul class="wp-block-list">
<li>Uber: 19%</li>
<li>Brookfield Corporation: 18%</li>
<li>Restaurant Brands International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QSR#NYSE">QSR</a>): 13%</li>
<li>Howard Hughes Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HHH#NYSE">HHH</a>): 12%</li>
<li>Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>): 9.1%</li>
</ul>
The latest 13F filing comes as Ackman is trying to&nbsp;<a href="https://www.benzinga.com/25/05/45401638/howard-hughes-rises-nearly-3-in-pre-market-as-bill-ackman-exits-from-universal-music-groups-board-to-prioritize-new-investments" target="_blank" rel="noreferrer noopener">buy control of&nbsp;</a>Howard Hughes and turn it into a diversified holding company to copy the conglomerate style of legendary investor&nbsp;Warren Buffett.
While investors could buy and hold the stocks that Ackman and others disclose they own each quarter, ETFs like this could take some of the legwork out. The inclusion of options, swaps, and other investing methods looks to generate additional income alongside any future gains from the legendary investors.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/hedge-funds/25/05/45499198/buffett-ackman-icahn-take-a-beating-as-billionaires-weather-q1-chaos">Buffett, Ackman, Icahn Take A Beating As Billionaires Weather Q1 Chaos</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Specialty ETFs

GOOGL

OMAH

UBER

New ETFs Let Investors Mirror Buffett, Ackman, Burry's Top Stock Trades

Scotiabank analyst Greg Harrison maintains Vera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) with a Sector Outperform and raises the price target from $55 to $65.

VERA

Scotiabank Maintains Sector Outperform on Vera Therapeutics, Raises Price Target to $65

<a href="https://www.ft.com/content/6df5a2c7-d9ae-49ac-a709-c478a3dd69dd" title="https://www.ft.com/content/6df5a2c7-d9ae-49ac-a709-c478a3dd69dd">https://www.ft.com/content/6df5a2c7-d9ae-49ac-a709-c478a3dd69dd</a>
<a href="https://www.ft.com/content/6df5a2c7-d9ae-49ac-a709-c478a3dd69dd">https://www.ft.com/content/6df5a2c7-d9ae-49ac-a709-c478a3dd69dd</a>

GOOG

'Google to spend $500M on compliance to settle shareholder antitrust suit'- Financial Times

Needham analyst Gil Blum reiterates Taysha Gene Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSHA#NASDAQ">TSHA</a>) with a Buy and raises the price target from $6 to $8.

Reiteration

TSHA

Needham Reiterates Buy on Taysha Gene Therapies, Raises Price Target to $8

WIIM

Molina Healthcare shares are trading lower after Barclays maintained an Equal-Weight rating on the stock but lowered its price target from $362 to $351.

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$240.00</td>
<td>$228.0K</td>
<td>6.9K</td>
<td>2.1K</td>
</tr>
<tr>
<td>SMR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$32.00</td>
<td>$27.0K</td>
<td>309</td>
<td>1.1K</td>
</tr>
<tr>
<td>RKLB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$25.00</td>
<td>$91.0K</td>
<td>11.2K</td>
<td>895</td>
</tr>
<tr>
<td>BA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$250.00</td>
<td>$62.1K</td>
<td>200</td>
<td>465</td>
</tr>
<tr>
<td>AAL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$11.00</td>
<td>$31.6K</td>
<td>8.4K</td>
<td>369</td>
</tr>
<tr>
<td>ZIM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$19.16</td>
<td>$79.9K</td>
<td>28.3K</td>
<td>187</td>
</tr>
<tr>
<td>UAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$82.00</td>
<td>$36.2K</td>
<td>198</td>
<td>169</td>
</tr>
<tr>
<td>CAR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$105.00</td>
<td>$32.4K</td>
<td>300</td>
<td>19</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$450.00</td>
<td>$30.8K</td>
<td>541</td>
<td>18</td>
</tr>
<tr>
<td>GWW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$1070.00</td>
<td>$51.0K</td>
<td>0</td>
<td>6</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For GE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), we notice a put option sweep that happens to be bearish, expiring in 46 day(s) on July 18, 2025. This event was a transfer of 300 contract(s) at a $240.00 strike. This particular put needed to be split into 19 different trades to become filled. The total cost received by the writing party (or parties) was $228.0K, with a price of $760.0 per contract. There were 6902 open contracts at this strike prior to today, and today 2111 contract(s) were bought and sold. 
• Regarding SMR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>), we observe a call option sweep with bullish sentiment. It expires in 74 day(s) on August 15, 2025. Parties traded 45 contract(s) at a $32.00 strike. This particular call needed to be split into 12 different trades to become filled. The total cost received by the writing party (or parties) was $27.0K, with a price of $600.0 per contract. There were 309 open contracts at this strike prior to today, and today 1177 contract(s) were bought and sold. 
• For RKLB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>), we notice a call option trade that happens to be bearish, expiring in 18 day(s) on June 20, 2025. This event was a transfer of 353 contract(s) at a $25.00 strike. The total cost received by the writing party (or parties) was $91.0K, with a price of $258.0 per contract. There were 11206 open contracts at this strike prior to today, and today 895 contract(s) were bought and sold. 
• For BA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), we notice a put option sweep that happens to be bullish, expiring in 592 day(s) on January 15, 2027. This event was a transfer of 12 contract(s) at a $250.00 strike. This particular put needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $62.1K, with a price of $5184.0 per contract. There were 200 open contracts at this strike prior to today, and today 465 contract(s) were bought and sold. 
• Regarding AAL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>), we observe a put option sweep with bullish sentiment. It expires in 109 day(s) on September 19, 2025. Parties traded 316 contract(s) at a $11.00 strike. This particular put needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $31.6K, with a price of $100.0 per contract. There were 8439 open contracts at this strike prior to today, and today 369 contract(s) were bought and sold. 
• For ZIM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>), we notice a put option sweep that happens to be bullish, expiring in 228 day(s) on January 16, 2026. This event was a transfer of 186 contract(s) at a $19.16 strike. This particular put needed to be split into 24 different trades to become filled. The total cost received by the writing party (or parties) was $79.9K, with a price of $430.0 per contract. There were 28300 open contracts at this strike prior to today, and today 187 contract(s) were bought and sold. 
• Regarding UAL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>), we observe a call option sweep with bearish sentiment. It expires in 18 day(s) on June 20, 2025. Parties traded 139 contract(s) at a $82.00 strike. This particular call needed to be split into 15 different trades to become filled. The total cost received by the writing party (or parties) was $36.2K, with a price of $261.0 per contract. There were 198 open contracts at this strike prior to today, and today 169 contract(s) were bought and sold. 
• For CAR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>), we notice a put option sweep that happens to be bullish, expiring in 381 day(s) on June 18, 2026. This event was a transfer of 17 contract(s) at a $105.00 strike. This particular put needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $32.4K, with a price of $1910.0 per contract. There were 300 open contracts at this strike prior to today, and today 19 contract(s) were bought and sold. 
• For GEV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>), we notice a call option trade that happens to be neutral, expiring in 46 day(s) on July 18, 2025. This event was a transfer of 6 contract(s) at a $450.00 strike. The total cost received by the writing party (or parties) was $30.8K, with a price of $5138.0 per contract. There were 541 open contracts at this strike prior to today, and today 18 contract(s) were bought and sold. 
• For GWW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWW#NYSE">GWW</a>), we notice a call option trade that happens to be bullish, expiring in 228 day(s) on January 16, 2026. This event was a transfer of 6 contract(s) at a $1070.00 strike. The total cost received by the writing party (or parties) was $51.0K, with a price of $8500.0 per contract. There were 0 open contracts at this strike prior to today, and today 6 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

RKLB

10 Industrials Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Consumer Discretionary sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/06/25</td>
<td>$360.00</td>
<td>$69.4K</td>
<td>13.4K</td>
<td>45.9K</td>
</tr>
<tr>
<td>AMZN</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/06/25</td>
<td>$205.00</td>
<td>$65.7K</td>
<td>4.6K</td>
<td>5.1K</td>
</tr>
<tr>
<td>GME</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$35.00</td>
<td>$45.9K</td>
<td>10.9K</td>
<td>1.5K</td>
</tr>
<tr>
<td>BABA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$115.00</td>
<td>$29.1K</td>
<td>4.0K</td>
<td>1.0K</td>
</tr>
<tr>
<td>SIG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/06/25</td>
<td>$67.00</td>
<td>$36.8K</td>
<td>52</td>
<td>786</td>
</tr>
<tr>
<td>EAT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$140.00</td>
<td>$26.0K</td>
<td>4.0K</td>
<td>583</td>
</tr>
<tr>
<td>DASH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/13/25</td>
<td>$210.00</td>
<td>$40.9K</td>
<td>1.1K</td>
<td>488</td>
</tr>
<tr>
<td>HD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$400.00</td>
<td>$26.1K</td>
<td>1.2K</td>
<td>156</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$51.00</td>
<td>$50.9K</td>
<td>795</td>
<td>123</td>
</tr>
<tr>
<td>DKNG</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$35.00</td>
<td>$37.5K</td>
<td>2.8K</td>
<td>103</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we notice a call option sweep that happens to be bullish, expiring in 4 day(s) on June 6, 2025. This event was a transfer of 250 contract(s) at a $360.00 strike. This particular call needed to be split into 23 different trades to become filled. The total cost received by the writing party (or parties) was $69.4K, with a price of $278.0 per contract. There were 13453 open contracts at this strike prior to today, and today 45900 contract(s) were bought and sold. 
• For AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we notice a put option trade that happens to be neutral, expiring in 4 day(s) on June 6, 2025. This event was a transfer of 274 contract(s) at a $205.00 strike. The total cost received by the writing party (or parties) was $65.7K, with a price of $240.0 per contract. There were 4670 open contracts at this strike prior to today, and today 5167 contract(s) were bought and sold. 
• Regarding GME (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>), we observe a call option sweep with bearish sentiment. It expires in 46 day(s) on July 18, 2025. Parties traded 200 contract(s) at a $35.00 strike. This particular call needed to be split into 20 different trades to become filled. The total cost received by the writing party (or parties) was $45.9K, with a price of $230.0 per contract. There were 10926 open contracts at this strike prior to today, and today 1569 contract(s) were bought and sold. 
• For BABA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), we notice a put option trade that happens to be bullish, expiring in 46 day(s) on July 18, 2025. This event was a transfer of 47 contract(s) at a $115.00 strike. The total cost received by the writing party (or parties) was $29.1K, with a price of $620.0 per contract. There were 4089 open contracts at this strike prior to today, and today 1044 contract(s) were bought and sold. 
• For SIG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>), we notice a call option sweep that happens to be bearish, expiring in 4 day(s) on June 6, 2025. This event was a transfer of 93 contract(s) at a $67.00 strike. This particular call needed to be split into 14 different trades to become filled. The total cost received by the writing party (or parties) was $36.8K, with a price of $384.0 per contract. There were 52 open contracts at this strike prior to today, and today 786 contract(s) were bought and sold. 
• For EAT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>), we notice a put option sweep that happens to be bearish, expiring in 74 day(s) on August 15, 2025. This event was a transfer of 65 contract(s) at a $140.00 strike. This particular put needed to be split into 29 different trades to become filled. The total cost received by the writing party (or parties) was $26.0K, with a price of $400.0 per contract. There were 4031 open contracts at this strike prior to today, and today 583 contract(s) were bought and sold. 
• For DASH (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>), we notice a call option sweep that happens to be bearish, expiring in 11 day(s) on June 13, 2025. This event was a transfer of 65 contract(s) at a $210.00 strike. This particular call needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $40.9K, with a price of $630.0 per contract. There were 1167 open contracts at this strike prior to today, and today 488 contract(s) were bought and sold. 
• Regarding HD (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>), we observe a call option sweep with bearish sentiment. It expires in 74 day(s) on August 15, 2025. Parties traded 87 contract(s) at a $400.00 strike. This particular call needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $26.1K, with a price of $298.0 per contract. There were 1290 open contracts at this strike prior to today, and today 156 contract(s) were bought and sold. 
• Regarding CMG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>), we observe a call option trade with bearish sentiment. It expires in 228 day(s) on January 16, 2026. Parties traded 100 contract(s) at a $51.00 strike. The total cost received by the writing party (or parties) was $50.9K, with a price of $510.0 per contract. There were 795 open contracts at this strike prior to today, and today 123 contract(s) were bought and sold. 
• Regarding DKNG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>), we observe a put option trade with neutral sentiment. It expires in 74 day(s) on August 15, 2025. Parties traded 100 contract(s) at a $35.00 strike. The total cost received by the writing party (or parties) was $37.5K, with a price of $375.0 per contract. There were 2846 open contracts at this strike prior to today, and today 103 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMZN

BABA

DASH

TSLA

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/06/25</td>
<td>$137.00</td>
<td>$27.4K</td>
<td>11.3K</td>
<td>100.0K</td>
</tr>
<tr>
<td>RGTI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/06/25</td>
<td>$13.00</td>
<td>$37.1K</td>
<td>1.9K</td>
<td>12.8K</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/06/25</td>
<td>$462.50</td>
<td>$713.1K</td>
<td>984</td>
<td>10.0K</td>
</tr>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$160.00</td>
<td>$44.0K</td>
<td>6.3K</td>
<td>4.4K</td>
</tr>
<tr>
<td>KOPN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$1.50</td>
<td>$30.0K</td>
<td>2.3K</td>
<td>2.0K</td>
</tr>
<tr>
<td>INTC</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$19.00</td>
<td>$77.6K</td>
<td>5.0K</td>
<td>1.5K</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/06/25</td>
<td>$240.00</td>
<td>$28.0K</td>
<td>2.6K</td>
<td>1.0K</td>
</tr>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$110.00</td>
<td>$61.6K</td>
<td>14.5K</td>
<td>742</td>
</tr>
<tr>
<td>AAPL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/13/25</td>
<td>$202.50</td>
<td>$25.4K</td>
<td>504</td>
<td>623</td>
</tr>
<tr>
<td>ARM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$125.00</td>
<td>$74.5K</td>
<td>1.2K</td>
<td>582</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we notice a call option sweep that happens to be bullish, expiring in 4 day(s) on June 6, 2025. This event was a transfer of 100 contract(s) at a $137.00 strike. This particular call needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $27.4K, with a price of $274.0 per contract. There were 11350 open contracts at this strike prior to today, and today 100067 contract(s) were bought and sold. 
• Regarding RGTI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>), we observe a call option sweep with bearish sentiment. It expires in 4 day(s) on June 6, 2025. Parties traded 2101 contract(s) at a $13.00 strike. This particular call needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $37.1K, with a price of $18.0 per contract. There were 1956 open contracts at this strike prior to today, and today 12878 contract(s) were bought and sold. 
• Regarding MSFT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), we observe a call option sweep with bearish sentiment. It expires in 4 day(s) on June 6, 2025. Parties traded 2228 contract(s) at a $462.50 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $713.1K, with a price of $320.0 per contract. There were 984 open contracts at this strike prior to today, and today 10077 contract(s) were bought and sold. 
• Regarding PLTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), we observe a call option trade with bearish sentiment. It expires in 74 day(s) on August 15, 2025. Parties traded 55 contract(s) at a $160.00 strike. The total cost received by the writing party (or parties) was $44.0K, with a price of $800.0 per contract. There were 6351 open contracts at this strike prior to today, and today 4498 contract(s) were bought and sold. 
• Regarding KOPN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>), we observe a call option trade with bullish sentiment. It expires in 46 day(s) on July 18, 2025. Parties traded 2000 contract(s) at a $1.50 strike. The total cost received by the writing party (or parties) was $30.0K, with a price of $15.0 per contract. There were 2316 open contracts at this strike prior to today, and today 2015 contract(s) were bought and sold. 
• For INTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), we notice a call option trade that happens to be neutral, expiring in 74 day(s) on August 15, 2025. This event was a transfer of 353 contract(s) at a $19.00 strike. The total cost received by the writing party (or parties) was $77.6K, with a price of $220.0 per contract. There were 5072 open contracts at this strike prior to today, and today 1531 contract(s) were bought and sold. 
• For AVGO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), we notice a call option trade that happens to be bullish, expiring in 4 day(s) on June 6, 2025. This event was a transfer of 20 contract(s) at a $240.00 strike. The total cost received by the writing party (or parties) was $28.0K, with a price of $1402.0 per contract. There were 2677 open contracts at this strike prior to today, and today 1037 contract(s) were bought and sold. 
• Regarding AMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), we observe a put option sweep with neutral sentiment. It expires in 109 day(s) on September 19, 2025. Parties traded 72 contract(s) at a $110.00 strike. This particular put needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $61.6K, with a price of $856.0 per contract. There were 14522 open contracts at this strike prior to today, and today 742 contract(s) were bought and sold. 
• For AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we notice a put option trade that happens to be bearish, expiring in 11 day(s) on June 13, 2025. This event was a transfer of 50 contract(s) at a $202.50 strike. The total cost received by the writing party (or parties) was $25.4K, with a price of $510.0 per contract. There were 504 open contracts at this strike prior to today, and today 623 contract(s) were bought and sold. 
• Regarding ARM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>), we observe a put option sweep with bullish sentiment. It expires in 74 day(s) on August 15, 2025. Parties traded 65 contract(s) at a $125.00 strike. This particular put needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $74.5K, with a price of $1147.0 per contract. There were 1255 open contracts at this strike prior to today, and today 582 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

AVGO

INTC

KOPN

MSFT

NVDA

PLTR

RGTI

10 Information Technology Stocks Whale Activity In Today's Session

Scotiabank maintains i-80 Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IAUX#AMEX">IAUX</a>) with a Sector Outperform and lowers the price target from $2.25 to $1.5.

IAUX

Scotiabank Maintains Sector Outperform on i-80 Gold, Lowers Price Target to $1.5

<a href="https://www.bloomberg.com/news/articles/2025-06-02/musk-s-xai-launches-5-billion-debt-sale-through-morgan-stanley" title="https://www.bloomberg.com/news/articles/2025-06-02/musk-s-xai-launches-5-billion-debt-sale-through-morgan-stanley">https://www.bloomberg.com/news/articles/2025-06-02/musk-s-xai-launches-5-billion-debt-sale-through-morgan-stanley</a>

'Musk's xAI Launches $5 Billion Debt Sale Through Morgan Stanley' - Bloomberg News

Zscaler Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) shares are trading higher Monday on what appears to be continued momentum after the company posted better-than-expected fiscal third-quarter earnings and raised its <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45700639/zscaler-stock-is-gaining-friday-whats-going-on">full-year guidance last week</a>.
What To Know: The cybersecurity firm reported adjusted earnings of 84 cents per share, beating analyst estimates of 75 cents per share and revenue of $678 million, which topped consensus forecasts of $666.86 million.
The results were driven by demand for Zscaler&#8217;s Zero Trust Exchange platform and increased customer adoption across its portfolio. Calculated billings climbed 26% year-over-year to $785 million, exceeding expectations. Annual recurring revenue (ARR) also grew 23% year-over-year to $2.9 billion.
Despite the positive results, Piper Sandler downgraded the stock to Neutral from Overweight, citing valuation concerns and potential risks tied to Zscaler&#8217;s recent Red Canary acquisition and federal sector uncertainty. Still, the firm raised its price target from $235 to $260.
Other analysts were more bullish. RBC, KeyBanc, Needham and Rosenblatt all increased their price targets, with Rosenblatt pushing its forecast to $315. Analysts highlighted Zscaler&#8217;s strong execution, growing momentum in key product areas like Zero Trust and AI-driven security and improving sales productivity. Several firms also noted the company did not report any negative impact from current tariffs, a positive sign in the current macro environment. Positive analyst changes continue to roll in this week with Canaccord Genuity lifting its target from $230 to $305.
Zscaler's management raised full-year 2025 revenue guidance to a range of $2.659 billion to $2.661 billion, slightly above analyst estimates. Full-year adjusted earnings are now expected to be between $3.18 and $3.19 per share, up from prior forecasts and well ahead of the Street&#8217;s $3.07 estimate.
ZS Price Action: Zscaler shares were up 5.89% at $291.94 at the time of writing. Zscaler shares are now up more than 61% year-to-date. The stock climbed to new 52-week highs on Monday, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/economic-data/25/06/45724821/trumps-manufacturing-narrative-weakens-as-may-data-shows-sharper-contraction-stubborn-inflation">Trump&#8217;s Manufacturing Narrative Weakens As May Data Shows Sharper Contraction, Stubborn Inflation </a></li>
</ul>
Image via Shutterstock.

Zscaler Shares Hit New 52-Week High: What's Driving The Momentum?

<ul class="wp-block-list">
<li>The U.S. has the largest number of high-net-worth individuals, according to a new report from Henley &amp; Partners and New World Health</li>
<li>37% of the global millionaire population, 36% of the world's centimillionaires, and 33% of billionaires call the country home</li>
<li>These ultra-wealthy individuals primarily live in or near major cities like New York, San Francisco, and Los Angeles</li>
</ul>
The U.S. is home to 37% of the global millionaire total, according to a new report from Henley &amp; Partners and New World Wealth.
The <a href="https://www.henleyglobal.com/newsroom/press-releases/usa-wealth-report-2025">USA Wealth Report</a> says that over 6 million high net worth individuals, defined as those with investable assets of $1 million or more, resided in the U.S. at the end of 2024. Additionally, 36% of the world's centimillionaires and 33% of the world's billionaires also call the country home.
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
</ul>
Over the past decade, the U.S. has seen its millionaire population increase by 78%. This growth slightly outpaces China, which saw its millionaire population increase by 74% between 2014 and 2024, and well outpaces other wealthy countries like Japan (5%), Canada (26%), Switzerland (28%), and the UK (-9%).&nbsp;
Tim Klatte, partner at Grant Thornton China, warns high net worth individuals that despite this incredible growth rate, they shouldn't get too comfortable. "The U.S.–China trade war is more than an economic battle — it is a complex geopolitical contest with far-reaching consequences," he said in a statement accompanying the report. "HNW investors must account for the risk of escalating tensions, potential breakdowns in trade negotiations, and the broader threat of international conflict. These geopolitical dynamics can significantly influence investment decisions, asset allocation, and long-term wealth preservation."
Trending: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
In fact, this economic unrest has led many ultra-wealthy Americans to explore their options when it comes to moving their wealth outside the US. According to the report, US citizens account for over 30% of all investment migration applications submitted through Henley &amp; Partners at this point in the year. A number that is nearly double the combined total of the next five investor nationalities, which include Turkish, Indian, and British.
"We're witnessing a new level of sophistication in how affluent Americans manage and diversify their wealth," says Basil Mohr-Elzeki, managing partner at Henley &amp; Partners North America. "Securing alternative residences and citizenships is now a strategic form of risk management — a thoughtful ‘Plan B' that enhances family resilience, unlocks global opportunities, and safeguards multigenerational legacies."
See Also: <a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a>
Within the U.S., high net worth individuals tend to congregate in areas the report calls "urban wealth hubs." New York City has the highest number of high net worth individuals, with 384,500 millionaires, 818 centimillionaires, and 66 billionaires. The San Francisco Bay Area, which includes Silicon Valley, is second with 342,400 millionaires, 756 centimillionaires, and 82 billionaires. Los Angeles, Chicago, and Dallas round out the top five.
"Despite a wave of policy changes and their subsequent implications around the world, the relative political stability, rule of law, economic prospects, culture of innovation, not to mention the US dollar remaining the global reserve currency, have squarely positioned the USA as an environment in which to do business and to invest," said David K. Young, president at the Committee for Economic Development of The Conference Board in a statement accompanying the report.
Read Next: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
Image: Shutterstock

Personal Finance

37% Of The World's Millionaires Call The US Home, Up 78% Over The Last Decade

RIVN

Rivian Automotive shares are trading lower after the company announced a proposed $1.25 billion senior secured green notes offering.

Scotiabank analyst Louise Chen downgrades Blueprint Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) from Sector Outperform to Sector Perform and announces $135 price target.

Downgrades

BPMC

Scotiabank Downgrades Blueprint Medicines to Sector Perform, Announces $135 Price Target

CGAU

RGLD

SSRM

USAU

Shares of precious metals stocks are trading higher as gold and silver prices rise amid dollar weakness.

JP Morgan analyst Brian Cheng downgrades Blueprint Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) from Overweight to Neutral and lowers the price target from $130 to $129.

JP Morgan Downgrades Blueprint Medicines to Neutral, Lowers Price Target to $129

Moderna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) shares are trading higher Monday after the company announced its new COVID-19 vaccine secured clearance from the U.S. Food and Drug Administration (FDA) for seniors and <a href="https://www.benzinga.com//node/45708511">at-risk individuals.</a>
What To Know: In a Phase 3 clinical trial, the new vaccine, mNEXSPIKE, showed a higher vaccine efficacy as well as a similar safety profile compared to the company&#8217;s original COVID-19 vaccine. 
&#8220;The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19,&#8221; said Stéphane Bancel, CEO of Moderna.
&#8220;COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA&#8217;s timely review and thank the entire Moderna team for their hard work and continued commitment to public health.&#8221;
Moderna expects to have mNEXSPIKE available for eligible populations in the U.S. for the 2025-2026 respiratory virus season. The new vaccine is under review with regulators in multiple markets around the world.
See Also: <a href="https://www.benzinga.com/news/25/06/45727221/vera-therapeutics-applied-digital-kymera-therapeutics-and-other-big-stocks-moving-higher-on-monday">Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday</a>
MRNA Price Action: At the time of writing, Moderna stock is trading 2.73% higher at $27.28, according to data from <a href="https://pro.benzinga.com/">Benzinga Pro.</a>
Image: Shutterstock.

MRNA

Moderna Stock Is Trading Higher Monday: What's Going On?

Press Releases

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2025 Financial Results and Pipeline Update

Arcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual Meeting

Arcus Biosciences Reports First-Quarter 2025 Financial Results and Provides a Pipeline Update

Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response

Comments

Arcus Biosciences

Arcus Biosciences (RCUS) オプション

Arcus Biosciences (NYSE:RCUS) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル